Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aura Biosciences, Inc. | Chief Medical Officer | Common Stock | 270K | $2.09M | $7.75 | Feb 18, 2025 | Direct |
Aura Biosciences, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 79.4K | Feb 3, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AURA | Aura Biosciences, Inc. | Feb 18, 2025 | 1 | -$19.6K | 4 | Feb 18, 2025 | Chief Medical Officer |
AURA | Aura Biosciences, Inc. | Feb 3, 2025 | 2 | $0 | 4 | Feb 4, 2025 | Chief Medical Officer |
AURA | Aura Biosciences, Inc. | Nov 18, 2024 | 1 | -$111K | 4 | Nov 18, 2024 | Chief Medical Officer |
AURA | Aura Biosciences, Inc. | Feb 1, 2024 | 2 | $0 | 4 | Feb 2, 2024 | Chief Medical Officer |
AURA | Aura Biosciences, Inc. | Nov 1, 2023 | 2 | $0 | 4 | Nov 3, 2023 | Chief Medical Officer |
AURA | Aura Biosciences, Inc. | Oct 16, 2023 | 0 | $0 | 3 | Oct 23, 2023 | Chief Medical Officer and President of Research and Development; Exhibit 24.1 - Power of Attorney |